-
I have posted this here before, but the $4.00 Generic Resource listings are a good all in one place to find what drugs are offered by the retailers at the discounted price. I appreciate the papers also spreading the word to others. Reuters was the first to circulate and the 2 other...
-
One more new generic coming on to the market for the treatment of Alzheimer's, after FDA approval, which is pending. Patent expires December 2008 but this article states that J and J will appeal ? It sounds like by the time all the red tape is cleared here that it just might be around...
-
A couple months ago, the product was approved by the FDA and is now coming to market. According to the article hospitals and health organizations will be the first visits for marketing and sales, rather than a direct to consumer sale. Intel also has a pretty large interest in biotech related...
-
No more buy one, get the second at 10% off, for a quick example. Physicians will no longer get discounts for prescribing drugs in a "bundled" package. We all are familiar with sales tactics as such is done in retail all the time, and instead the drugs will be offered up front at...
-
This bring up a very good point with all the recent budget cuts, why does it take Medicare so long to realize the savings? Camptosar is not on the $4.00 generic listings, as all generics do not make the list, but worth checking. One resource I used to find out more about the drug was the...
-
Interesting video from Microsoft, Johnson and Johnson and the Discovery Channel on how health care will be in the not too distant future. I tripped out a bit on the toothbrush taking my pulse here, but as the video states, these are all thing either here now or in development. BD ...
-
This is hot stuff! Recently I had an in depth interview with Dr. Patrice Milos, Chief Scientific Officer at Helicos discussing genomics and where the future is going. Helicos has the software and the genomics machine, and wouldn't this be a nice addition to run on Surface. This...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
08-27-2008
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, Microsoft/Windows News, Hospital, Genomics, healthcare, microsoft, Surface, Cardiology, Touch Screen, HIMMS, Surface Technology, Helicos, Heart Transplant, MSDN, Scripps, Healthblog
-
The New York Times has a series of these and they are good with patients speaking from all walks of life. There are more for other conditions as well, and very well done. Thought with all the recent news this one would not be bad to include here. BD What is it like to get a diagnosis...
-
The drug, Avastin is used by physicians as an off label alternative, especially if the other one is out of range for the patient's budget...and there's still the pending buy out from Roche still on the agenda amidst all of this. BD WASHINGTON - What does a company do when there's...
-
Only requires a blood sample, but the cost is not cheap, but neither is a heart transplant. If one were having a transplant, this could be very valuable to know up front about potential rejection issues that would arise after the fact. BD The Food and Drug Administration said the test...
-
This comes as no surprise as most of us have probably all done this at some point in time. Antibiotics and pain medications lead the race here. I've done it when a family member had the same anti-biotic I was taking. There are other dangers though beyond this level, what if you...
-
No additional studies required, just more information, as is required for any decision process it seems today. Can't blame the FDA with the area of responsibility they have in desiring to have all the information they require for a sound decision. BD Johnson & Johnson(JNJ -...
-
Now that is has been approved, you may ask your pharmacy for more information as to when it will be available. This looks to be very convenient and will fit in to a purse nicely as the video at the site shows. I talk about mobility all the time with information technology and here's medical...
-
The process is using digital automation to more accurately guide the process with treating blocked arteries, and is integrated with other technologies from other companies. Cardiology with all the new processes and software available today is getting pretty deep, as far as understanding what is...
-
This could be a helping hand in getting the required information to the FDA for medical devices with the format and information they need and could save time in having all the information together at once and potentially avoid some letters sent by the FDA asking for additional information. Processes...